Form DEFM14A - Definitive proxy statement relating to merger or acquisition:
SEC Accession No. 0000950135-08-004394
Filing Date
2008-06-17
Accepted
2008-06-16 18:56:23
Documents
6
Effectiveness Date
2008-06-17

Document Format Files

Seq Description Document Type Size
1 BENTLEY PHARMACEUTICALS, INC. b69071dfdefm14a.htm DEFM14A 1088016
2 GRAPHIC b69071dfb6907102.gif GRAPHIC 1928
3 GRAPHIC b69071dfb6907104.gif GRAPHIC 1344
4 GRAPHIC b69071dfb6907101.gif GRAPHIC 1113
5 GRAPHIC b69071dfb6907100.gif GRAPHIC 1189
6 GRAPHIC b69071dfb6907103.gif GRAPHIC 3445
  Complete submission text file 0000950135-08-004394.txt   1102737
Mailing Address BENTLEY PARK 2 HOLLAND WAY EXETER NH 03833
Business Address BENTLEY PARK 2 HOLLAND WAY EXETER NH 03833 6036586100
BENTLEY PHARMACEUTICALS INC (Filer) CIK: 0000821616 (see all company filings)

EIN.: 591513162 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFM14A | Act: 34 | File No.: 001-10581 | Film No.: 08901593
SIC: 2834 Pharmaceutical Preparations